UCL-led trial shows adding niraparib to standard therapy reduces tumour growth risk in men with advanced prostate cancer by up to 37%, with greater effect in specific genetic subgroups.
Having lifted most of its COVID regulations – spikes in infections show that UK herd immunity through vaccination programmes is not efficient in the long run.
The World Health Organisation (WHO) say that the XE COVID variant (a mixture of two strains of Omicron) could be 10% more transmissible than Omicron itself.
Access to fertility freezing treatments is becoming more scarce, as UK policy guidelines on fertility preservation are rigorous and NHS funding is “variable”.
A team at Rutgers University have figured out how to regenerate tissue for spinal injury symptoms - using AI and robotics to create therapeutic proteins.
